HighMark Wealth Management’s Transmedics TMDX Stock Holding History

HighMark Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.07K	Buy	41 +1	+3%	+$130	﹤0.01%	403
2025 Q4	$4.87K	Hold	40	–	–	﹤0.01%	408
2025 Q3	$4.49K	Hold	40	–	–	﹤0.01%	411
2025 Q2	$5.36K	Hold	40	–	–	﹤0.01%	388
2025 Q1	$2.69K	Hold	40	–	–	﹤0.01%	430
2024 Q4	$2.49K	Hold	40	–	–	﹤0.01%	443
2024 Q3	$6.28K	Hold	40	–	–	﹤0.01%	373
2024 Q2	$6.03K	Hold	40	–	–	﹤0.01%	359
2024 Q1	$2.96K	Hold	40	–	–	﹤0.01%	425
2023 Q4	$3.16K	Hold	40	–	–	﹤0.01%	420
2023 Q3	$2.19K	Hold	40	–	–	﹤0.01%	445
2023 Q2	$3.36K	Buy	+40	New	+$3.06K	﹤0.01%	405

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighMark Wealth Management's TMDX Position: Q1 2026 in Review

HighMark Wealth Management increased its Transmedics (TMDX) stake by 2.5% in Q1 2026, buying an estimated $130 and bringing the position to 41 shares worth $4.07K. The position accounts for ﹤0.01% of the portfolio, ranked #403.

HighMark Wealth Management first reported a position in TMDX in Q2 2023 and has held it in 12 quarters since. The position peaked at $6.28K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

HighMark Wealth Management held 41 shares of Transmedics worth $4.07K as of Q1 2026.
HighMark Wealth Management bought 1 Transmedics share in Q1 2026, an estimated $130.
Transmedics made up ﹤0.01% of HighMark Wealth Management's portfolio in Q1 2026, its #403 holding.
HighMark Wealth Management first reported a position in Transmedics in Q2 2023 and has held it in 12 quarters since.
HighMark Wealth Management's Transmedics position peaked at $6.28K in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.